MarketInOut Stock Screener Log In | Sign Up

Daehan New Pharm Co Ltd

KRX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:30
Daehan New Pharm Co Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization72,843 mln
Float7.99 mln

EPS

1,705
Exceptional

P / E

3.05
Deeply undervalued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.22
Caution advised

Relative Strength

54 / 100
Slightly ahead

Debt / Equity

0.72
Moderate leverage

Business Description

Founded in 1984 and based in Hwaseong-si, South Korea, Daehan Nupharm is a pharmaceutical company that develops and sells a broad range of medicines for human and animal use, both at home and abroad. Its human health products cover a wide variety of medical needs, from heart and hormone conditions to pain relief, cancer treatment, and skin care, alongside vitamins and mineral-based products. The company also offers animal health and nutrition products, dietary supplements, and medical aesthetic devices.

Key Fundamentals

EPS1,705
P/E3.05
ROE17.29
RPS15,068
ROIC4.28
ROA8.98
Interest Cover5.44
EBITDA, mln32,081
EV / EBITDA4.37
EV / EBIT5.14
Revenue, mln211,483
EV / Revenue0.66

Quote Details

Last 5,200.00
Change 40 (0.78%)
Open 5,220.00
Volume 3,204
Turnover 16,660,801
Average Volume 13,072

Financial Ratios

Pre-Tax Profit Margin12
Current Ratio1.76
Price / Book0.52
Price / Tangible Book0.52
Debt / Equity0.72
Price / Sales0.36

Financial Strength

Altman Z-Score2.05
Piotroski F-Score 5 / 9
Beneish M-Score-2.22
Price to Intrinsic Value1.64
Price to Graham Number0.39
Shiller PE Ratio9.82

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.38% 62 / 100   
1 Month -4.06% 60 / 100   
2 Months -6.14% 45 / 100   
6 Months -27.27% 44 / 100   
1 Year -21.78% 38 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog